TrialLupus science & medicine2022

Iberdomide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled, ascending-dose, phase 2a study.

Richard A Furie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.